December 2017 Vol 3 No 6
On July 17, 2017, the FDA approved Nerlynx (neratinib; from Puma Biotechnology) for long-term adjuvant treatment of early-stage, HER2-positive breast cancer in patients who received previous therapy with Herceptin (trastuzumab). Read More ›
By Ethan Hawes
The majority of people diagnosed with multiple myeloma are age 60 or older; Ethan was only 22. Read about Ethan Hawes’ journey with multiple myeloma, which started with debilitating hip pain when he returned home from studying abroad. Read More ›
Dr. Bruce Gershenhorn explores 3 questions patients should ask after learning they have lung cancer. Knowledge is power. Read More ›
Online communities and message boards are terrific options for patients with cancer and survivors to connect and chat with experts and other patients. Take a look at the role online communities serve for survivors in today’s digital world. Read More ›
“I have become an ally with fellow survivors, and have gained profound personal growth, which has ignited in me a passion to do the things I want to accomplish in life,” says Christine Magnus Moore, RN, BSN. Read More ›
Jason Micheli, a pastor and the author of Cancer is Funny: Keeping Faith in Stage-Serious Chemo, explains his mindset and the difficulties of dealing with uncertainty after a lymphoma diagnosis. Read More ›
By Laura Morgan
Unlike many types of cancers, the number of new cases of liver cancer, specifically hepatocellular carcinoma—the most common type of liver cancer—is increasing in the US. Read about the pressures, including the unmet needs, of caregivers of those affected by liver cancer. Read More ›
By Dana Taylor
CAR T-cell therapy is a new type of immunotherapy that uses the patient’s genetically modified immune T-cells to attack cancer cells. In 2017, the FDA approved the first 2 CAR T-cell therapies for several types of blood cancer. Read More ›
In today’s busy news environment—with its 24-hour story cycles, social media platforms, and flood of information—phony medical news spreads like the flu. Read More ›
Breast cancer survivor Lisa D’Ottavio describes the side effects of treatment that she experienced, from chemo hair loss, neuropathy, and lymphedema, to radiation effects and more. Read More ›